Foster Wayne

CIK 00017097692 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001709769

Recent Transactions

30 trades

Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2026-01-31−8,000→ 0 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2026-01-31+108,000→ 108,000 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2026-01-31+41,333→ 91,461 total
Tax Payment
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2026-01-31$4.24/sh−12,132→ 79,329 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2026-01-31−33,333→ 0 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2025-01-31−33,333→ 33,333 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-31+33,333→ 54,190 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-31+8,000→ 62,190 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2025-01-31+120,100→ 120,100 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2025-01-31+8,000→ 8,000 total
Tax Payment
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2025-01-31$3.06/sh−12,062→ 50,128 total
Sale
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-02-01$3.84/sh−12,477→ 20,857 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2024-01-31+120,100→ 120,100 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Common Stock
2024-01-31+33,334→ 33,334 total
Exercise/Conversion
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2024-01-31−33,334→ 66,666 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Restricted Stock Units
2023-01-31+100,000→ 100,000 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2023-01-31+140,000→ 140,000 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2022-01-31+120,000→ 120,000 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2021-01-29+71,750→ 71,750 total
Award
Atea Pharmaceuticals, Inc.$AVIR
Stock Option (Right to Buy)
2020-10-29+40,000→ 40,000 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2019-01-23+30,750→ 30,750 total
Award
Mersana Therapeutics, Inc.$MRSN
Stock Option (right to buy)
2018-02-02+20,250→ 20,250 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Option to Purchase Common Stock
2018-01-30−3,262→ 8,155 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2018-01-30$1.62/sh+889→ 57,267 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2018-01-30$1.53/sh+8,055→ 65,322 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Option to Purchase Common Stock
2018-01-30−889→ 889 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2018-01-30$6.98/sh+2,499→ 71,083 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Common Stock
2018-01-30$4.10/sh+3,262→ 68,584 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Option to Purchase Common Stock
2018-01-30−2,499→ 10,834 total
Exercise/Conversion
Mersana Therapeutics, Inc.$MRSN
Option to Purchase Common Stock
2018-01-30−8,055→ 12,084 total

Companies

Recent Filings

Address

225 FRANKLIN STREET SUITE 2100

BOSTON, MA, 02110

View on SEC.gov